English   español  
Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/141966
Título

GSE4, a small dyskerin- and GSE24.2-related peptide, induces telomerase activity, cell proliferation and reduces DNA damage, oxidative stress and cell senescence in dyskerin mutant cells

AutorIarriccio, Laura; Manguan-García, Cristina ; Pintado-Berninches, Laura ; Mancheño, Jose M. ; Molina, A.; Perona Abellón, Rosario ; Sastre, Leandro
Fecha de publicación2015
EditorPublic Library of Science
CitaciónPLoS ONE 10 (2015)
ResumenDyskeratosis congenita is an inherited disease caused by mutations in genes coding for telomeric components. It was previously reported that expression of a dyskerin-derived peptide, GSE24.2, increases telomerase activity, regulates gene expression and decreases DNA damage and oxidative stress in dyskeratosis congenita patient cells. The biological activity of short peptides derived from GSE24.2 was tested and one of them, GSE4, that probed to be active, was further characterized in this article. Expression of this eleven amino acids long peptide increased telomerase activity and reduced DNA damage, oxidative stress and cell senescence in dyskerin-mutated cells. GSE4 expression also activated c-myc and TERT promoters and increase of c-myc, TERT and TERC expression. The level of biological activity of GSE4 was similar to that obtained by GSE24.2 expression. Incorporation of a dyskerin nuclear localization signal to GSE24.2 did not change its activity on promoter regulation and DNA damage protection. However, incorporation of a signal that increases the rate of nucleolar localization impaired GSE24.2 activity. Incorporation of the dyskerin nuclear localization signal to GSE4 did not alter its biological activity. Mutation of the Aspartic Acid residue that is conserved in the pseudouridine synthase domain present in GSE4 did not impair its activity, except for the repression of c-myc promoter activity and the decrease of c-myc, TERT and TERC gene expression in dyskerin-mutated cells. These results indicated that GSE4 could be of great therapeutic interest for treatment of dyskeratosis congenita patients.
Versión del editorhttps://doi.org/10.1371/journal.pone.0142980
URIhttp://hdl.handle.net/10261/141966
DOI10.1371/journal.pone.0142980
Identificadoresdoi: 10.1371/journal.pone.0142980
issn: 1932-6203
Aparece en las colecciones: (IIBM) Artículos
(IQFR) Artículos
Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
journal.pone.0142980.PDF4,65 MBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro completo
 

Artículos relacionados:


NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.